379 related articles for article (PubMed ID: 26433839)
1. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
Olsen EA
Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
[TBL] [Abstract][Full Text] [Related]
2. Bridging the specialty gap: Update on primary cutaneous lymphomas.
Olsen EA; Hodak E; Geskin L; Scarisbrick J;
J Am Acad Dermatol; 2024 Feb; 90(2):257-260. PubMed ID: 38043039
[No Abstract] [Full Text] [Related]
3. Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region.
Pileri A; Morsia E; Zengarini C; Torre E; Goteri G; Quaglino P; Pimpinelli N; Paulli M; Pileri SA; Zinzani PL; Rupoli S
Eur J Dermatol; 2023 Aug; 33(4):360-367. PubMed ID: 37823487
[TBL] [Abstract][Full Text] [Related]
4. Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.
Jiang TT; Cao S; Kruglov O; Virmani A; Geskin LJ; Falo LD; Akilov OE
J Invest Dermatol; 2024 May; 144(5):1088-1098. PubMed ID: 38036289
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series.
Tang H; Matsumoto N; Foss F; Xu M; Ahmed A
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e405-e410. PubMed ID: 37659965
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study.
D'Onghia M; Cartocci A; Calabrese L; Maio D; Sirchio A; Erasti M; Tognetti L; Rubegni P; Bocchia M; Cencini E; Fabbri A; Cinotti E
Curr Oncol; 2023 Nov; 30(11):9813-9823. PubMed ID: 37999132
[TBL] [Abstract][Full Text] [Related]
7. An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma.
Hu M; Scheffel J; Elieh-Ali-Komi D; Maurer M; Hawro T; Metz M
Clin Exp Med; 2023 Dec; 23(8):4177-4197. PubMed ID: 37555911
[TBL] [Abstract][Full Text] [Related]
8. Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma.
Muszbek N; Remak E; Xin Q; McNamara L; Jones T
J Comp Eff Res; 2023 Jul; 12(7):CER. PubMed ID: 37338181
[No Abstract] [Full Text] [Related]
9. Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors.
Quadri I; Reneau JC; Hanel W; Chung CG
Front Immunol; 2023; 14():1291259. PubMed ID: 38022633
[TBL] [Abstract][Full Text] [Related]
10. Eyelid involvement of primary cutaneous lymphomas: A clinical perspective.
Baykal C; Atci T
Australas J Dermatol; 2023 Nov; 64(4):463-475. PubMed ID: 37435706
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous T-cell Lymphomas: A Single-center Retrospective Analysis.
Kaemmerer T; Guertler A; Clanner-Engelshofen BM; Fuchs C; French LE; Reinholz M
Acta Dermatovenerol Croat; 2023 Dec; 31(4):184-190. PubMed ID: 38651844
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates.
Saleh JS; Subtil A; Hristov AC
Hum Pathol; 2023 Oct; 140():75-100. PubMed ID: 37802757
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of mature T/NK-cell lymphomas in Germany - A representative cross-sectional study based on SHI claims data.
Assaf C; Dobos G; Zech IM; Doess A; May M; Jadasz J
J Dtsch Dermatol Ges; 2023 Nov; 21(11):1320-1327. PubMed ID: 37845021
[TBL] [Abstract][Full Text] [Related]
14. Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments.
Stuver R; Geller S
Front Immunol; 2023; 14():1284045. PubMed ID: 37868986
[TBL] [Abstract][Full Text] [Related]
15. The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets.
Guglielmo A; Zengarini C; Agostinelli C; Motta G; Sabattini E; Pileri A
Cells; 2024 Mar; 13(7):. PubMed ID: 38607023
[TBL] [Abstract][Full Text] [Related]
16. Immunopathogenesis and therapy of cutaneous T cell lymphoma.
Kim EJ; Hess S; Richardson SK; Newton S; Showe LC; Benoit BM; Ubriani R; Vittorio CC; Junkins-Hopkins JM; Wysocka M; Rook AH
J Clin Invest; 2005 Apr; 115(4):798-812. PubMed ID: 15841167
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.
Ion A; Popa IM; Papagheorghe LM; Lisievici C; Lupu M; Voiculescu V; Caruntu C; Boda D
Dis Markers; 2016; 2016():9602472. PubMed ID: 27821903
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
